Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

research

I love it when I get to use the phrase ‘company maker’, but it doesn’t happen so often. Today, Canabo Medical (CMM.V) got to pull out the company maker…
My doctor is a little more progressive than most. He likes to take medication away from new patients, as an example, preferring to start from scratch and work on…
Biotech research outfit Veritas Pharma (VRT.C), which has locked up a multitude of big academics as it seeks to lock down the best strains to deal with pain and…
A year back, I was hitting the medical marijuana sector pretty hard in terms of coverage, writing regularly about everyone from the giants in the making to the companies…
Veritas Pharma (VRT.C), the medical marijuana research stock that took a two week hit as a large investor dumped his stock to market, rebounded fully today on a day…
Yesterday, I wrote a quick story about how Veritas Pharma (VRT.C) had jumped 15% or so after a mild sell-off the week before. By the time I’d posted it,…
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail,…
Last December, Canadian Liberal Party mover/shaker, founding partner in Canopy Growth Corporation (CGC.V) and private equity player Chuck Rifici bought Wikileafs, the best named dispensary price comparison app out…
Medicinal cannabis research startup Veritas Pharmaceuticals (VRT.C) had a good day Tuesday when they received approval from Health Canada to legally perform cannabis research. Whistler Medical Marijuana will be…
Regular readers (of my as yet un-launched site) will know I’ve been talking to Veritas Pharma (VRT.C) over the last few weeks. I’m liking the business more and more,…